Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada · Delayed Price · Currency is CAD 1.800
-0.100 (-5.26%)
Nov 6, 2026, 12:48 PM EST
TSXV:EBM Income Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 0.81 | 0.78 | 0.7 | 0.87 | 1.3 | 0.98 | |
Revenue Growth | 36.59% | 11.39% | -19.11% | -33.22% | 32.49% | 36.57% |
Cost of Revenue | 0.24 | 0.23 | 0.25 | 0.32 | 0.4 | 0.52 |
Gross Profit | 0.57 | 0.55 | 0.45 | 0.55 | 0.9 | 0.46 |
Selling, General & Admin | 0.72 | 0.77 | 0.72 | 0.91 | 0.9 | 0.92 |
Amortization of Goodwill & Intangibles | 0.03 | 0.04 | 0.11 | 0.11 | 0.11 | 0.11 |
Operating Expenses | 0.75 | 0.82 | 0.84 | 1.02 | 1.01 | 1.03 |
Operating Income | -0.18 | -0.27 | -0.38 | -0.47 | -0.11 | -0.57 |
Interest Expense | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 | -0 |
Interest & Investment Income | 0 | - | - | - | - | - |
Currency Exchange Gain (Loss) | -0.01 | -0.03 | -0.01 | -0.01 | -0.01 | - |
Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0.06 | -0.03 | -0.02 | -0.05 |
EBT Excluding Unusual Items | -0.23 | -0.33 | -0.46 | -0.55 | -0.15 | -0.62 |
Other Unusual Items | - | - | - | - | - | 0.02 |
Pretax Income | -0.23 | -0.33 | -0.46 | -0.55 | -0.15 | -0.6 |
Net Income | -0.23 | -0.33 | -0.46 | -0.55 | -0.15 | -0.6 |
Net Income to Common | -0.23 | -0.33 | -0.46 | -0.55 | -0.15 | -0.6 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 69 | 69 | 69 | 69 | 69 | 69 |
Shares Outstanding (Diluted) | 69 | 69 | 69 | 69 | 69 | 69 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.01 | -0.00 | -0.01 |
EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.01 | -0.00 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Free Cash Flow | -0.01 | 0.02 | -0.02 | -0.02 | -0.01 | -0.12 |
Free Cash Flow Per Share | - | - | - | - | - | -0.00 |
Gross Margin | 70.13% | 70.45% | 64.72% | 63.18% | 69.45% | 46.72% |
Operating Margin | -22.03% | -34.13% | -54.24% | -54.42% | -8.60% | -58.07% |
Profit Margin | -28.51% | -42.55% | -64.93% | -62.98% | -11.53% | -61.52% |
Free Cash Flow Margin | -1.16% | 2.47% | -2.17% | -1.95% | -0.56% | -12.41% |
EBITDA | -0.15 | -0.22 | -0.27 | -0.42 | -0.06 | -0.52 |
EBITDA Margin | -18.17% | -28.38% | -38.92% | -48.87% | -4.97% | -53.42% |
D&A For EBITDA | 0.03 | 0.04 | 0.11 | 0.05 | 0.05 | 0.05 |
EBIT | -0.18 | -0.27 | -0.38 | -0.47 | -0.11 | -0.57 |
EBIT Margin | -22.03% | -34.13% | -54.24% | -54.42% | -8.60% | -58.07% |
Revenue as Reported | 0.81 | 0.78 | 0.7 | 0.87 | 1.3 | 0.98 |
Advertising Expenses | - | - | - | 0 | 0 | 0.02 |